This review assesses the range and quality of the evidence base on the cost
-effectiveness of malaria prevention and treatment in sub-Saharan Africa. F
ourteen studies are reviewed, covering insecticide-treated nets, residual s
praying, chemoprophylaxis far children, chemoprophylaxis or intermittent tr
eatment for pregnant women, a hypothetical vaccine, and changing the first
line drug for treatment. The available evidence provides some guidance to d
ecision-makers. However, the potential to inform policy debates is limited
by the gross lack of information on the costs and effects of many intervent
ions, the very small number of cost-effectiveness analyses available, the l
ack of evidence on the costs and effects of packages of measures, and the p
roblems in generalizing or comparing studies that relate to specific settin
gs and use different methodologies and outcome measures.